Analysis of Pathway Activity in Primary Tumors and NCI60 Cell Lines Using Gene Expression Profiling Data
暂无分享,去创建一个
Xi Lin | Shuyu Li | Xingdong Feng | Xiang Ye | Birong Liao | Eric W. Su | Shu-Guang Huang | Jian-Yong Shou | Jonathan M. Yingling | Lawrence M. Gelbert | Jude E. Onyia | L. Gelbert | E. Su | J. Yingling | Xingdong Feng | S. Li | J. Onyia | X. Ye | Xi Lin | J. Shou | Birong Liao | Shu-Guang Huang
[1] J. Minna,et al. Comparison of features of human breast cancer cell lines and their corresponding tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] K. Kinzler,et al. The Genetic Basis of Human Cancer , 1997 .
[3] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[4] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[5] J. Yingling,et al. Development of TGF-beta signalling inhibitors for cancer therapy. , 2004, Nature reviews. Drug discovery.
[6] Norhanom Abdul Wahab,et al. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction. , 2002, International journal of molecular medicine.
[7] E. Lander,et al. Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.
[8] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[9] W. Isaacs,et al. ras gene mutations in human prostate cancer. , 1990, Cancer research.
[10] J. Masters. HeLa cells 50 years on: the good, the bad and the ugly , 2002, Nature Reviews Cancer.
[11] T. Orfeo,et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.
[12] Kevin Camphausen,et al. Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[14] J. Minna,et al. Comparison of features of human lung cancer cell lines and their corresponding tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] Alexander Kamb,et al. What's wrong with our cancer models? , 2005, Nature Reviews Drug Discovery.
[16] Jonathan M. Yingling,et al. Development of TGF-β signalling inhibitors for cancer therapy , 2004, Nature Reviews Drug Discovery.
[17] J. Welsh,et al. Molecular classification of human carcinomas by use of gene expression signatures. , 2001, Cancer research.
[18] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] E. Lander,et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.
[20] T. Golub,et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.
[21] Shuguang Huang,et al. Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data , 2006, BMC Genomics.
[22] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] J W Moul,et al. Infrequent RAS oncogene mutations in human prostate cancer , 1992, The Prostate.
[24] Hongyu Zhao,et al. Pathway analysis using random forests classification and regression , 2006, Bioinform..
[25] Ho-Keung Ng,et al. Detection of Multiple Gene Amplifications in Glioblastoma Multiforme Using Array-Based Comparative Genomic Hybridization , 2001, Laboratory Investigation.
[26] Maximilian Burger,et al. Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations. , 2006, European urology.
[27] William Stafford Noble,et al. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] R. deVere White,et al. Activated ras alleles in human carcinoma of the prostate are rare. , 1991, Cancer research.
[29] H. Garewal,et al. Analysis of K-ras gene mutations in malignant and nonmalignant endobronchial tissue obtained by fiberoptic bronchoscopy. , 1995, American journal of respiratory and critical care medicine.
[30] Paul Workman,et al. Expression of Kinase-defective Mutants of c-Src in Human Metastatic Colon Cancer Cells Decreases Bcl-xL and Increases Oxaliplatin- and Fas-induced Apoptosis* , 2004, Journal of Biological Chemistry.